Eledon Pharmaceuticals (ELDN) Change in Account Payables (2013 - 2017)

Eledon Pharmaceuticals (ELDN) has 5 years of Change in Account Payables data on file, last reported at -$154000.0 in Q1 2017.

• Quarterly Change in Account Payables fell 122.71% year-over-year to -$154000.0 in Q1 2017, while the trailing twelve-month figure through Mar 2017 was -$1.6 million (down 4.01% YoY) and the FY2016 annual result came in at -$778000.0, down 275.62% from the prior year.
• Change in Account Payables improved to -$154000.0 in Q1 2017, from -$456000.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $2.7 million in Q1 2015 to a low of -$1.8 million in Q2 2015.
• A 5-year average of -$46785.7 and a median of -$222500.0 in 2014 frame the typical range for Change in Account Payables.
• Annual changes were most pronounced in 2015 — Change in Account Payables soared 234.46% — and 2016, when it slumped 5233.33%.
• Tracing ELDN's Change in Account Payables over 5 years: stood at -$926000.0 in 2013, then retreated by 21.38% to -$1.1 million in 2014, then soared by 60.5% to -$444000.0 in 2015, then retreated by 2.7% to -$456000.0 in 2016, then soared by 66.23% to -$154000.0 in 2017.
• The last three Change in Account Payables figures came in at -$154000.0 (Q1 2017), -$456000.0 (Q4 2016), and -$960000.0 (Q3 2016), per Business Quant data.